Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL8979578 | 0.77 | ALDH1A1 (0.50) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL704300 | 0.76 | ALDH1A1 (0.37) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL9806380 | 0.76 | ALDH1A1 (0.59) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL10608308 | 0.73 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL152443 | 0.72 | ALDH1A1 (0.54) | ALDH1A1TSHRMAPT | |
| SCHEMBL2016639 | 0.72 | ALDH1A1 (0.54) | ALDH1A1TSHRMAPT | |
| SCHEMBL1562120 | 0.71 | ALDH1A1 (0.59) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL50012 | 0.70 | ALDH1A1 (0.65) | ALDH1A1TSHRPOLBCA1CA2 | |
| SCHEMBL1647493 | 0.70 | ALDH1A1 (0.65) | ALDH1A1TSHRPOLBCA1CA2 | |
| Styrene SCHEMBL28820879 | 0.70 | ALDH1A1 (0.82) | ALDH1A1TSHRPOLBLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8604249-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2013-12-10 | — | — | US | disclosed |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | PHOSPHO1, BRI3BP, CA4 | ALDH1A1 3637/4885TSHR 1382/4885POLB 1364/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.